Atellica CH IP 11097611Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Phosphorus (IP) Atellica CH - RGT 5100T · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414596303), received between Nov 20, 2025 and Nov 20, 2025 — classified as 1 malfunction.
The most frequently reported specific device problem is “High Test Results” (1 report).
3 other recalls cover devices cleared under the same FDA submission (K991576); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 20, 2025High Test Results; High Test Results
THE CUSTOMER REPORTED TO SIEMENS THEY OBTAINED AN ERRONEOUSLY ELEVATED INORGANIC PHOSPHORUS (IP) RESULT ON ONE (1) PATIENT SAMPLE ON AN ATELLICA CH 930 ANALYZER. THE ERRONEOUSLY ELEVATED RESULT WAS NOT REPORTED TO THE PHYSICIAN. THE SAME SAMPLE WAS REPROCESSED ON THE ORIGINAL ATELLICA CH 930 ANALYZER. A LOWER RESULT WAS OBTAINED, CONSIDERED CORRECT, AND REPORTED TO THE PHYSICIAN. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ERRONEOUSLY ELEVATED INORGANIC PHOSPHORUS (IP) RESULT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23605977 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K991576. One submission often covers many models, so check the product and lot details in each record.
- Z-1498-2022 · Jun 28, 2022 · Open, ClassifiedAtellica CH Iron_2 (Iron_2) is for in vitro diagnostic use in the quantitative determination of iron in human serum and (lithium heparin) plasma samples.
- Z-2062-2018 · Mar 27, 2018 · TerminatedADVIA Chemistry Urea Nitrogen Reagent (material number 10309051) for use on ADVIA 1800, 2400 and XPT Chemistry Systems
- Z-1658-2016 · Mar 17, 2016 · TerminatedAdvia Chemistry Assay: Uric Acid and Uric Acid, concentrated
Other Phosphomolybdate (colorimetric), inorganic phosphorus devices
- VITROS 1513209Ortho-Clinical Diagnostics, Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 recall0 reports
- Synchron 467868Beckman Coulter, Inc. · Phosphomolybdate (Colorimetric), Inorganic Phosphorus1 recall0 reports
- Phosphate (Inorganic) ver.2 03183793122Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus11 reports
- Phosphate (Inorganic) ver.2 5171377190Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus5 reports
- Phosphate (Inorganic) ver.2 08058610190Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus4 reports
- ARCHITECT 7D71-23Abbott GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus2 reports
- Dimension Vista® Flex® reagent cartridge PHOS 10445144Siemens Healthcare Diagnostics Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 report
- Dimension® Flex® reagent cartridge PHOS 10720277Siemens Healthcare Diagnostics Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page